About Careers Internship MedBlog Contact us

Europe Watchdog Worried About Prescription Drug Abuse

by Dr. Enozia Vakil on May 27, 2014 at 10:18 PM
 Europe Watchdog Worried About Prescription Drug Abuse

A new report has revealed that though the use of heroin in Europe is declining, more people are now getting their fix from prescription drugs, and some are even using them to deal with addiction.

It also warned of a flood of new, synthetic drugs, and of established ones like ecstasy and cannabis becoming more potent.


"The drug phenomenon is dynamic and continues to evolve, leaving us no room for complacency as new threats emerge," Wolfgang Goetz, director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), wrote in an introduction to the latest European Drug Report.

It highlighted abuse of synthetic opioids -- the class of drugs to which heroin belongs -- including methadone and buprenorphine that are used in substitution treatment.

Like heroin, they are addictive but safer, partly because as they are taken by mouth rather than injected.

"In 2012, 17 countries reported that over 10 percent of first-time opioid clients entering specialist treatment were misusing opioids other than heroin," said the report.

In some countries, these drugs now represent the most common form of opioid abuse -- like in Finland where buprenorphine is most popular.

The report warned of a "plethora" of new substances emerging, with 81 previously unknown psychoactive substances signalled in 2013 to bring the total to 350.

These seek to replace drugs that are strictly controlled under national or international laws. Unregulated, they are marketed as "legal highs" or disguised as herbal incense, bath salts, jewellery cleaner or even plant food.

The report warned that ecstasy and cannabis appeared to be getting stronger, their active ingredients boosted in the lab.

"I am deeply concerned that the drugs consumed in Europe today may be even more damaging to users' health than in the past," said European Commissioner for Home Affairs Cecilia Malmstroem.

- Pot still popular -

More than 80 million Europeans, about a quarter of the adult population, are estimated to have used illicit drugs at some point in their lives.

Most (73.6 million) used cannabis -- 18.1 million in the last year. Marijuana and hashish are consumed at a rate of about 2,000 tonnes per year.

Cocaine was in second place with 14.1 million people having used it (3.1 million in the last year measured), followed by amphetamines with 11.4 million users ever (1.5 million in the last year).

The agency quoted a recent analysis of raw sewage in 42 cities in 21 European countries, which calculated that 832 kilogrammes (1,800 pounds) of cocaine were consumed daily in Europe's cities -- led by Amsterdam, Antwerp, London and Zurich.

Dutch cities also led in the use of ecstasy as well as cannabis, in which they were closely followed by Paris, Athens and Barcelona.

One in four 15- to 16-year-olds are estimated to have used an illicit drug, mainly marijuana, said the EMCDDA report.

Cannabis accounted for about 80 percent of the one million drug seizures each year, followed by cocaine and crack with nine percent, heroin with four percent, amphetamines with three percent, ecstasy two percent, and methamphetamine and LSD with one percent each.

Cannabis was also the drug most frequently cited in 2012 as the reason for seeking drug treatment for the first time.

While opioid use is on the decline -- from 59,000 new clients in 2007 to 31,000 in 2012, there are still about 1.3 million "problem" users in Europe, said the report.

Heroin was the major cause of the 6,100 overdose deaths recorded in Europe in 2012 -- down from 6,500 in 2011 and 7,100 in 2009. Estonia, Norway, Ireland, Sweden and Finland have the highest overdose rates.

Cocaine accounted for some 500 deaths in 2012, said the report, compared to some 10,000-20,000 opioid deaths each year.

The report said the rise in substitute opioid use may partly explain recent outbreaks of HIV among drug users in Greece and Romania, long a problem in some Baltic countries and traditionally associated with heroin injection.

And it raised concerns about the Internet as a growing marketplace.

"The fact that manufacturers, suppliers, retailers, website-hosting and payment processing services may all be based in different countries makes it particularly difficult to control," said the document.

Source: AFP
Font : A-A+



Recommended Readings

Latest Research News

Insight into Cellular Stress: Mechanisms Behind MRNA Sequestration Revealed
The discovery deepens our understanding of m6A biology and stress granule formation, with implications for neurodegenerative diseases.
Disrupted Circadian Rhythm Elevates the Risk of Parkinson's Disease
Trouble with sleep and the body's clock may increase your risk for Parkinson's, as per a new study.
A Wake-Up Call for Women  Hot Flashes Could Point to Alzheimer's Risk
New study uncovers a link between nocturnal hot flashes and Alzheimer's risk in menopausal women, suggesting a potential biomarker.
Breakthrough Brain-Centered Approach Reduces Chronic Back Pain
Our discovery revealed that a minority of individuals attributed their chronic pain to their brain's involvement.
New Statement to Protect Athletes' Health Published
Relative Energy Deficiency in Sport syndrome is overlooked by athletes and can be worsened by 'sports culture' due to its perceived short-term performance benefits.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Europe Watchdog Worried About Prescription Drug Abuse Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests